List of Valsoft Anju CTMS Master Customers
Montreal, H4T 1Z2, QC,
Canada
Since 2010, our global team of researchers has been studying Valsoft Anju CTMS Master customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Valsoft Anju CTMS Master for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Valsoft Anju CTMS Master for Clinical Trial Management include: ClinChoice, a United States based Life Sciences organisation with 4000 employees and revenues of $750.0 million, Gustave Roussy France, a France based Healthcare organisation with 3200 employees and revenues of $420.0 million, Sofpromed, a Spain based Life Sciences organisation with 30 employees and revenues of $2.0 million and many others.
Contact us if you need a completed and verified list of companies using Valsoft Anju CTMS Master, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Valsoft Anju CTMS Master customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ClinChoice | Life Sciences | 4000 | $750M | United States | Valsoft Corporation | Valsoft Anju CTMS Master | Clinical Trial Management | 2023 | n/a |
In 2023 ClinChoice expanded its eClinical footprint with Valsoft Anju CTMS Master. The deployment in June 2023 incorporated Anju TrialMaster and the broader Anju eClinical suite to deliver Clinical Trial Management capabilities across the Americas, Europe and APAC, with an explicit aim to accelerate study delivery and improve scalability.
Valsoft Anju CTMS Master and TrialMaster were configured to provide combined CTMS and EDC functionality, covering study tracking, site and investigator management, electronic data capture workflows, monitoring visit orchestration, and query resolution processes. The implementation narrative treats CTMS Master usage as an integral component of the Anju eClinical suite, aligning operational modules with clinical operations and data management teams.
Operational coverage included clinical operations, data management, and study delivery processes across multiple regions, leveraging the Anju eClinical suite to standardize workflows and centralize study oversight. The engagement focused on improving clinical operations and trial data workflows, with governance and process standardization implied by a single eClinical platform supporting cross-region study execution.
The ClinChoice Valsoft Anju CTMS Master Clinical Trial Management relationship centers on enabling operational scalability and global study delivery through unified eClinical and EDC capabilities, aligning clinical operations and trial data workflows across sites and regions.
|
 |
Gustave Roussy France | Healthcare | 3200 | $420M | France | Valsoft Corporation | Valsoft Anju CTMS Master | Clinical Trial Management | 2017 | n/a |
In 2017, Gustave Roussy France implemented Valsoft Anju CTMS Master as an expansion of Anju's eClinical footprint after adopting TrialMaster EDC to support complex oncology studies. The institute renewed its TrialMaster EDC agreement in January 2022 after five years of EDC use, reflecting continued reliance on Anju products for study data capture and submission readiness across France and Europe.
Valsoft Anju CTMS Master was configured to deliver core Clinical Trial Management capabilities including study configuration, subject lifecycle tracking, visit scheduling, site management, monitoring activity tracking, centralized operational reporting, and query management. Configuration emphasized alignment with EDC-driven workflows to support data reconciliation and preparation for regulatory submissions, extending TrialMaster EDC workflows into CTMS-managed operational processes.
The implementation targeted clinical operations, data management, and study oversight teams supporting oncology trials across Gustave Roussy's France and Europe operations. Governance workstreams formalized data management processes, monitoring schedules, and submission readiness procedures to enhance trial data quality and operational consistency. Valsoft Anju CTMS Master serves as the CTMS component of the Anju eClinical platform at Gustave Roussy and remains part of the vendor engagement lifecycle documented by the 2022 renewal.
|
|
|
Sofpromed | Life Sciences | 30 | $2M | Spain | Valsoft Corporation | Valsoft Anju CTMS Master | Clinical Trial Management | 2019 | n/a |
In 2019, Sofpromed selected TrialMaster EDC and pursued deployment of Valsoft Anju CTMS Master to strengthen clinical data workflows. The work was scoped to Clinical Trial Management for a Spain based oncology CRO running Phase I to IV oncology trials across Europe and the United States.
Deployment centered on electronic data capture, structured reporting, and SDTM export capability, aligning TrialMaster EDC capabilities with CTMS oriented coordination for study setup, subject tracking, and data reconciliation. The Valsoft Anju CTMS Master implementation is inferred from Anju and OmniComm's eClinical suite context and emphasizes centralized data management and regulatory dataset packaging.
Operational coverage included Phase I to IV oncology studies across Europe and the United States, with primary business functions impacted being clinical operations and data management. Integrations prioritized SDTM export workflows for regulatory dataset delivery and study level reporting pipelines, rather than introducing additional named system integrations.
Governance adjustments focused on standardized data quality controls, study reporting governance, and operational processes to accelerate regulatory dataset delivery. The implementation targeted improved clinical operations, higher data quality, and faster regulatory dataset delivery as described in the deployment notes.
|
Buyer Intent: Companies Evaluating Valsoft Anju CTMS Master
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||